Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06840327

Impact of VARIation of OXYdo-reduction Potential in Cardiac Surgery on Post-operative Outcome

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Observational, prospective, monocentric study conducted in the cardiac surgery department about biological markers to predict the short-term outcome of heart surgery patients.

Detailed description

At present, there are no biological markers to predict the short-term outcome of heart surgery patients. Redox balance, determined by the interaction between oxidants and reducers in tissues, is an essential parameter in the regulation of cellular functions. Cardiac surgery with extracorporeal circulation (CEC) induces major disturbances in this balance. In preliminary work, it was observed that the redox potential (Eg) varied with the introduction of CEC, and a persistent imbalance appeared to correlate with post-operative complications. It is believed that Eg potential could be a new biomarker of the post-operative outcome of major surgery.

Conditions

Interventions

TypeNameDescription
OTHERBlood and tissue samplesBlood samples will be taken from catheters placed for the purpose of surgery (arterial and venous catheters), or during routine venipunctures. (D-1 pre-op). Tissue samples will be taken from surgical waste generated by the surgery. They will therefore not require any additional incisions or surgical procedures.
OTHERwalking testThe study includes a walking test between D5 and D7.

Timeline

Start date
2025-03-01
Primary completion
2027-06-01
Completion
2027-06-01
First posted
2025-02-21
Last updated
2025-02-21

Source: ClinicalTrials.gov record NCT06840327. Inclusion in this directory is not an endorsement.